Renqiang Ma

818 total citations
45 papers, 605 citations indexed

About

Renqiang Ma is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Renqiang Ma has authored 45 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Physiology and 7 papers in Oncology. Recurrent topics in Renqiang Ma's work include Asthma and respiratory diseases (10 papers), Allergic Rhinitis and Sensitization (6 papers) and Epigenetics and DNA Methylation (6 papers). Renqiang Ma is often cited by papers focused on Asthma and respiratory diseases (10 papers), Allergic Rhinitis and Sensitization (6 papers) and Epigenetics and DNA Methylation (6 papers). Renqiang Ma collaborates with scholars based in China, United States and Australia. Renqiang Ma's co-authors include Weiping Wen, Huabin Li, Yihui Wen, Wei‐Zen Sun, Lin Chen, Xingmei Wu, Zhiwei Wang, Xi Luo, Hua‐Bin Li and Geng Xu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Renqiang Ma

45 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renqiang Ma China 15 272 144 121 115 111 45 605
Shyun-Yeu Liu Taiwan 17 339 1.2× 170 1.2× 169 1.4× 254 2.2× 57 0.5× 24 755
Justine Bellier Belgium 11 270 1.0× 159 1.1× 130 1.1× 211 1.8× 55 0.5× 11 632
Rodolfo Chavez-Dominguez Mexico 6 288 1.1× 142 1.0× 90 0.7× 119 1.0× 44 0.4× 12 562
Ye Xu China 12 367 1.3× 227 1.6× 46 0.4× 129 1.1× 62 0.6× 18 593
Yueling Liao China 16 425 1.6× 206 1.4× 121 1.0× 234 2.0× 131 1.2× 25 710
Hyun Gyu Lee South Korea 16 326 1.2× 108 0.8× 82 0.7× 136 1.2× 40 0.4× 23 599
Su‐Jin Yoo South Korea 13 208 0.8× 59 0.4× 118 1.0× 46 0.4× 56 0.5× 31 494
Chie Nakashima Japan 17 348 1.3× 215 1.5× 54 0.4× 143 1.2× 81 0.7× 43 607
Kela Liu Canada 12 253 0.9× 78 0.5× 62 0.5× 49 0.4× 67 0.6× 23 562

Countries citing papers authored by Renqiang Ma

Since Specialization
Citations

This map shows the geographic impact of Renqiang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renqiang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renqiang Ma more than expected).

Fields of papers citing papers by Renqiang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renqiang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renqiang Ma. The network helps show where Renqiang Ma may publish in the future.

Co-authorship network of co-authors of Renqiang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Renqiang Ma. A scholar is included among the top collaborators of Renqiang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renqiang Ma. Renqiang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yi, Renqiang Ma, Wei Sun, et al.. (2025). Nomogram Prediction of Response to Neoadjuvant Chemotherapy Plus Pembrolizumab in Locally Advanced Hypopharyngeal Squamous Cell Carcinoma. Journal of Otolaryngology - Head and Neck Surgery. 54. 2071642095–2071642095. 2 indexed citations
2.
Ma, Renqiang, Sijia Li, Xiaojuan Chen, et al.. (2024). Preventive and Therapeutic Effects of Crocetin in Rats with Heart Failure. Pharmaceuticals. 17(4). 496–496. 1 indexed citations
3.
Ying, Xiaoling, et al.. (2024). tsRNA modifications: An emerging layer of biological regulation in disease. Journal of Advanced Research. 74. 403–414. 9 indexed citations
4.
5.
Sun, Wei, Yihui Wen, Renqiang Ma, et al.. (2022). CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma. Frontiers in Immunology. 13. 952059–952059. 20 indexed citations
6.
Zhao, Yi, Zhiyu Zhang, Wenbin Lei, et al.. (2021). IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer. Frontiers in Oncology. 11. 648293–648293. 13 indexed citations
7.
Peng, Liang, Qingquan Lv, Fan Yang, et al.. (2021). The interval between onset and admission predicts disease progression in COVID-19 patients. Annals of Translational Medicine. 9(3). 213–213. 4 indexed citations
8.
Sun, Wei‐Zen, Renqiang Ma, Weiping Wen, & Xiaolin Zhu. (2020). Treatment Principle Based on the Clinical Staging of Pharyngocutaneous Fistula. SHILAP Revista de lepidopterología. 2020. 1–4. 1 indexed citations
9.
Li, Hang, Yihui Wen, Dehua Chen, et al.. (2019). Epigenetic Modification of Enhancer of Zeste Homolog 2 Modulates the Activation of Dendritic Cells in Allergen Immunotherapy. International Archives of Allergy and Immunology. 180(2). 120–127. 15 indexed citations
10.
Chen, Siqi, Jie Fan, Minghui Zhang, et al.. (2019). CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy. Nature Communications. 10(1). 150–150. 68 indexed citations
11.
Li, Hang, Wei‐Zen Sun, Renqiang Ma, et al.. (2019). Ten-Eleven Translocation (TET) Enzymes Modulate the Activation of Dendritic Cells in Allergic Rhinitis. Frontiers in Immunology. 10. 2271–2271. 15 indexed citations
12.
Wei, Yi, Renqiang Ma, Jia Zhang, et al.. (2018). Excessive periostin expression and Th2 response in patients with nasal polyps: association with asthma. Journal of Thoracic Disease. 10(12). 6585–6597. 18 indexed citations
13.
Wu, Pei‐zhe, Wei‐Zen Sun, Yihui Wen, et al.. (2017). Misdiagnosed paranasal gossypiboma: a 10-year experience with 21 cases at a tertiary center. Rhinology Journal. 55(3). 1 indexed citations
14.
Luo, Qing, Jia Zhang, Hongtian Wang, et al.. (2015). Expression and Regulation of Transcription Factor FoxA2 in Chronic Rhinosinusitis With and Without Nasal Polyps. Allergy Asthma and Immunology Research. 7(5). 458–458. 20 indexed citations
15.
Feng, Shaoyan, et al.. (2015). Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis. European Archives of Oto-Rhino-Laryngology. 273(11). 3477–3486. 12 indexed citations
16.
Liu, Zhe, Yiming Sun, Haiyu Hong, et al.. (2015). 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells.. PubMed. 5(9). 2673–85. 15 indexed citations
17.
Ma, Renqiang, Xi Luo, Shaoyan Feng, et al.. (2014). Osteopontin Promotes EZH2 Expression and Tumor Progression in Nasopharyngeal Carcinoma. ORL. 76(5). 273–281. 4 indexed citations
18.
Feng, Shaoyan, et al.. (2014). Cluster Subcutaneous Allergen Specific Immunotherapy for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-Analysis. PLoS ONE. 9(1). e86529–e86529. 12 indexed citations
19.
Ma, Renqiang, et al.. (2014). Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis. European Archives of Oto-Rhino-Laryngology. 272(5). 1165–1173. 5 indexed citations
20.
Hou, Weijian, Weiling He, Yuhuang Li, et al.. (2013). Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness. European Archives of Oto-Rhino-Laryngology. 271(1). 171–179. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shyun-Yeu Liu Breakdown of academic impact, for papers by Justine Bellier Breakdown of academic impact, for papers by Rodolfo Chavez-Dominguez Breakdown of academic impact, for papers by Ye Xu Breakdown of academic impact, for papers by Yueling Liao Breakdown of academic impact, for papers by Hyun Gyu Lee Breakdown of academic impact, for papers by Su‐Jin Yoo Breakdown of academic impact, for papers by Chie Nakashima Breakdown of academic impact, for papers by Kela Liu
Rankless by CCL
2026